Search by Drug Name or NDC

    NDC 00781-9253-94 Azacitidine 100 mg/1 Details

    Azacitidine 100 mg/1

    Azacitidine is a INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is AZACITIDINE.

    Product Information

    NDC 00781-9253
    Product ID 0781-9253_f7cb6926-a333-41dc-8700-b181ba7250dd
    Associated GPIs 21300003001920
    GCN Sequence Number 054660
    GCN Sequence Number Description azacitidine VIAL 100 MG INJECTION
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 22663
    HICL Sequence Number 026361
    HICL Sequence Number Description AZACITIDINE
    Brand/Generic Generic
    Proprietary Name Azacitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name azacitidine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name AZACITIDINE
    Labeler Name Sandoz Inc
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA050794
    Listing Certified Through n/a

    Package

    NDC 00781-9253-94 (00781925394)

    NDC Package Code 0781-9253-94
    Billing NDC 00781925394
    Package 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-9253-94)
    Marketing Start Date 2014-03-27
    NDC Exclude Flag N
    Pricing Information N/A